ABSTRACT
Objectives To assess the association of Long COVID with housing insecurity in the United States.
Methods To compare the prevalence of 3 binary indicators of housing insecurity between people with Long COVID (symptoms > 3 months) and COVID-19 survivors who don’t report long-term symptoms, we used survey-weighted regression models on 203,807 responses from the Household Pulse Survey, a representative cross-sectional survey of US households collected September 2022 – April 2023. Among people with Long COVID, we assessed whether functional impairment, current COVID-19 related symptoms, and symptom impact on day-to- day life were associated with a higher prevalence of housing insecurity.
Results During the study period, 54,446 (27.2%) respondents with COVID-19 experienced symptoms lasting 3 months or longer, representing an estimated 27 million US adults. People with Long COVID were nearly twice as likely to experience significant difficulty with household expenses (Prevalence ratio [PR] 1.85, 95% CI 1.74-1.96), be behind on housing payments (PR 1.76, 95% CI 1.57-1.99), and face likely eviction or foreclosure (PR 2.12, 95% CI 1.58-2.86). Functional limitation and current symptoms which impact day-to-day life were associated with higher prevalence of housing insecurity.
Conclusions Compared with COVID-19 survivors who don’t experience long-term symptoms, people with Long COVID are more likely to report indicators housing insecurity, particularly those with functional limitations and long-term COVID-19 related symptoms impacting day-to- day life. Policies are needed to support people living with chronic illnesses following SARS- CoV-2 infection.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by National Institute of Mental Health #T32-MH013043
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study exclusively used publicly available, de-identified data from the US Census Bureau Household Pulse Survey. These data were made publicly available prior to the analyses performed in this study, and can be accessed at https://www.census.gov/programs-surveys/household-pulse-survey/datasets.html
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Added language in introduction section, more clarity was added in the discussion regarding interpretation of results.
Data Availability
Data used in this present work are publicly available online at https://www.census.gov/programs-surveys/household-pulse-survey/datasets.html
https://www.census.gov/programs-surveys/household-pulse-survey/datasets.html
